Fundraising FoxTopo Therapeutics
Cambridge, US · Founded 2024 · 3 known investors
Find your way into Topo Therapeutics
Sign up to see every warm intro you have to Topo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Topo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Topo Therapeutics is a drug discovery company developing treatments targeting ion channels and transmembrane proteins for conditions such as pain, epilepsy, and CNS, pulmonary, and renal diseases. It is built around scientific advisors and leadership with expertise in ion channel biology and biophysics.
Founders & leadership
Board
Investors · 3
How we know: MRL Ventures Fund's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: SR One Capital Management's portfolio page · Not right? Tell us
How we know: The Column Group's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 1 round · 2024
▶$10.6MraisedDec 2024 · 4 investors · BiotechnologyRule 506(b)
- Bruce BeanDirector
- Hui TianExecutive Officer, Director
- Madgalene MoranExecutive Officer, Director
- Karin KleinhansDirector
- James Jeffrey Goater, Jr.Director
- Offering amount
- $95M
- Amount sold
- $10.6M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Topo Therapeutics went on to found or lead other companies.
Frequently asked questions
- What does Topo Therapeutics do?
- Topo Therapeutics is a drug discovery company developing treatments targeting ion channels and transmembrane proteins for conditions such as pain, epilepsy, and CNS, pulmonary, and renal diseases. It is built around scientific advisors and leadership with expertise in ion channel biology and biophysics.
- Who are Topo Therapeutics's investors?
- Topo Therapeutics's investors include MRL Ventures Fund, SR One Capital Management, The Column Group.
- How much funding has Topo Therapeutics raised?
- Topo Therapeutics has disclosed $10.6M raised across 1 round.
- Where is Topo Therapeutics headquartered?
- Topo Therapeutics is headquartered in Cambridge, US.